 |
|
 |
|
| News |  |
|
|
| Firmen | |
|
|
| Industrieinformationen | |
|
|
| Journale | |
|
|
| Bücher | |
|
|
| Events | |
|
|
| Hotlinks | |
|
|
| Newsletter abonnieren | |
|
|
| Impressum | |
|
|
|
|
|
Elan Pharma GmbH
Rosenkavalierplatz 8 81925 München Tel.: 089/99 99 7030 Fax: 089/99 99 7040
Elan Corporation, plc (Elan), began in 1969 with a vision: to approach the challenge of drug delivery from an entirely new angle—that of controlled absorption of a drug by the patient’s body. Over the years, Elan became a world leader in drug delivery and specialty pharmaceuticals. Today, Elan is a fully integrated biopharmaceutical company, pioneering exciting new research and development in Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, pain management and autoimmune diseases. At Elan's core is a passion to discover and develop innovative products that will fulfill the unmet medical needs of patients. Elan is headquartered in Dublin, Ireland and conducts its worldwide business, including research and development, manufacturing, and marketing through wholly-owned subsidiaries incorporated in Ireland, the United States, the United Kingdom, and other countries. The term "Elan" is used throughout this website to collectively refer to Elan Corporation, plc and its subsidiary companies.
[zurück] |
|
|
